<!DOCTYPE html>
<html lang="en-gb">
<head>
  
  <meta charset="utf-8" />
  <meta content="IE=edge,chrome=1" name="X-UA-Compatible" />
  <meta content="width=device-width, initial-scale=1, maximum-scale=1" name="viewport" />
  
  <!-- meta tags -->
  <meta content="NICE" name="DC.Publisher" />
  <meta content="All content on this site is NICE copyright unless otherwise stated. You can download material for private research, study or in-house use only. Do not distribute or publish any material from this site without first obtaining NICE's permission. Where Crown copyright applies, see the Office of Public Sector Information (formerly HMSO) website for information." name="DC.Rights.Copyright" />
  <meta content="eng" name="DC.Language" scheme="DCTERMS.ISO639-2T" />
  <meta content="Health, well-being and care" name="DC.Subject" scheme="eGMS.IPSV" />
  <meta content="Double-A" name="eGMS.accessibility" scheme="eGMS.WCAG10" />
  <meta content="2014-08-05" name="DC.Issued" scheme="DCTERMS.W3CDTF" />
  <meta content="2014-08-05" name="DC.Modified" scheme="DCTERMS.W3CDTF" />
  <meta content="CorporatePage" name="DC.Type" scheme="NICE.Publication.Types" />
  
  <meta content="BNF: British National Formulary - NICE" name="DC.Title" />
  
  <title>METHADONE HYDROCHLORIDE | Drug | BNF content published by NICE</title>
  <meta name="description" content="Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for METHADONE HYDROCHLORIDE."/>
  <meta name="author" content="NICE - The National Institute for Health and Care Excellence" />

  	<link rel="alternate" type="application/json" href="/drug/methadone-hydrochloride.json" title="RDF/JSON version of this document"/>
  	<link rel="alternate" type="text/turtle" href="/drug/methadone-hydrochloride.ttl" title="Turtle version of this document"/>
  <!--[if lt IE 9]>
  <script src="//cdn.nice.org.uk/V3.1/Scripts/html5shiv/html5shiv.js"></script>
  <![endif]-->
  
  <!-- Le styles -->
  <link href="//fonts.googleapis.com/css?family=Lato:300normal,300italic,400normal,400italic,700normal,700italic" rel="stylesheet"/>
  <link href="//cdn.nice.org.uk/V3.1/Content/NICE.bootstrap.css" rel="stylesheet">
  <link rel="stylesheet" href="//maxcdn.bootstrapcdn.com/font-awesome/4.5.0/css/font-awesome.min.css">
  
  <!--[if IE 7]>
  <link href="//cdn.nice.org.uk/V3.1/Content/NICE.glyphs-ie7.css" rel="stylesheet"/>
  <![endif]-->
  
  <meta content="#f6f6f6" name="msapplication-TileColor" />
  <meta content="//cdn.nice.org.uk/V3.1/Content/nice/favicon-144.png" name="msapplication-TileImage" />
  <link rel="shortcut icon" href="//cdn.nice.org.uk/V3.1/Content/nice/favicon.ico" />
  <link rel="apple-touch-icon-precomposed" href="//cdn.nice.org.uk/V3.1/Content/nice/favicon-152.png">
  
  <link href="/styles/style.css" rel="stylesheet" type="text/css" />
  <link href="/styles/bnf.css" rel="stylesheet" type="text/css" />
</head>
<body id="methadone-hydrochloride" class="drug" data-publication="bnf" data-buildnumber="1.0.119-Live" data-release="live">
  
  
  <!-- Google Tag Manager -->
  <div id='gtmscript'></div>
  <noscript>
    <iframe src="//www.googletagmanager.com/ns.html?id=GTM-WF3WHX"
      height="0" width="0" style="display:none;visibility:hidden"></iframe>
  </noscript>
  <script>
    (function (w, d, s, l, i) {
      w[l] = w[l] || []; w[l].push({
        'gtm.start': new Date().getTime(), event: 'gtm.js'
      }); var f = d.getElementsByTagName(s)[0],
              j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
                '//www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
    })(window, document, 'script', 'dataLayer', 'GTM-WF3WHX');
  </script>
  <!-- End Google Tag Manager -->
  <div id="global-nav-header"></div>  <div class="container topic-container">
    
    <ul class="breadcrumb">
      <li><a href="../">Home</a> <span class="divider icon-nice-chevron-right"></span></li>
      <li><a href="./">Drugs</a> <span class="divider icon-nice-chevron-right"></span></li>
      <li class="active"><span>METHADONE HYDROCHLORIDE</span></li>
    </ul>
  </div>
  
	<div class="container sticky-notice">
			<div id="site-distinction" class="bnf">
				<p>You are viewing BNF. If you require BNF for Children, use <a href="https://bnfc.nice.org.uk">BNFC.</a></p>
			</div>	</div>

  <div class="layout search-container hidden">
    <div id="search-results">
    </div>
  </div>
  <div class="layout">
    <h1 id=""><span>METHADONE HYDROCHLORIDE</span></h1>
  </div>


  <div class="layout layout-secondary-wide topic-container">

    <div class="content content-primary">
      <nav class="nav-toggle">
        <ul class="index unstyled nav-subtopics">
          <li>
            <a class="btn btn-transparent">
              <i class="pull-right icon-chevron-down"></i>
              <span>Show all parts of this monograph</span>
            </a>
          </li>
        </ul>
      </nav>

      <nav class="monograph-navigation">
        <ul class="index unstyled nav-subtopics grid2">
            <li class="active"><a href="#indicationsAndDoses" class="scroll-to-href">Indications and dose</a></li>
            <li><a href="#unlicensedUse" class="scroll-to-href">Unlicensed use</a></li>
            <li><a href="#importantSafetyInformations" class="scroll-to-href">Important safety information</a></li>
            <li><a href="#contraIndications" class="scroll-to-href">Contra-indications</a></li>
            <li><a href="#cautions" class="scroll-to-href">Cautions</a></li>
          <li><a href="#interactions" class="scroll-to-href">Interactions</a></li>
            <li><a href="#sideEffects" class="scroll-to-href">Side-effects</a></li>
            <li><a href="#pregnancy" class="scroll-to-href">Pregnancy</a></li>
            <li><a href="#breastfeeding" class="scroll-to-href">Breast feeding</a></li>
            <li><a href="#hepaticImpairment" class="scroll-to-href">Hepatic impairment</a></li>
            <li><a href="#renalImpairment" class="scroll-to-href">Renal impairment</a></li>
            <li><a href="#treatmentCessationInformation" class="scroll-to-href">Treatment cessation</a></li>
            <li><a href="#directionsForAdministration" class="scroll-to-href">Directions for administration</a></li>
            <li><a href="#prescribingAndDispensingInformations" class="scroll-to-href">Prescribing and dispensing information</a></li>
            <li><a href="#patientAndCarerAdvice" class="scroll-to-href">Patient and carer advice</a></li>
            <li><a href="#nationalFunding" class="scroll-to-href">National funding/access decisions</a></li>
            <li><a href="#lessSuitableForPrescribings" class="scroll-to-href">Less suitable for prescribing</a></li>
            <li><a href="#medicinalForms" class="scroll-to-href">Medicinal forms</a></li>
        </ul>
      </nav>

      <div id="monograph-content" class="">
      
        <section class="scroll-target" id="indicationsAndDoses">
          <h2>Indications and dose</h2>
      
      
          <div class="prescribingInformation">
          <section class="indicationsAndDose">
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Severe pain</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By mouth, or by subcutaneous injection, or by intramuscular injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>5&#8211;10&#8239;mg every 6&#8211;8&#8239;hours, adjusted according to response, on prolonged use not to be given more frequently than every 12 hours.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Adjunct in treatment of opioid dependence</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By mouth using oral solution</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>Initially 10&#8211;30&#8239;mg daily, increased in steps of 5&#8211;10&#8239;mg daily if required until no signs of withdrawal nor evidence of intoxication, dose to be increased in the first week, then increased every few days as necessary up to usual dose, maximum weekly dose increase of 30&#8239;mg; usual dose 60&#8211;120&#8239;mg daily.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Adjunct in treatment of opioid dependence if tolerance low or not known</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By mouth using oral solution</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>Initially 10&#8211;20&#8239;mg daily, increased in steps of 5&#8211;10&#8239;mg daily if required until no signs of withdrawal nor evidence of intoxication, dose to be increased in the first week, then increased every few days as necessary up to usual dose, maximum weekly dose increase of 30&#8239;mg; usual dose 60&#8211;120&#8239;mg daily.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Adjunct in treatment of opioid dependence if tolerance high (under expert supervision)</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By mouth using oral solution</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>Initially up to 40&#8239;mg daily, increased in steps of 5&#8211;10&#8239;mg daily if required until no signs of withdrawal nor evidence of intoxication, dose to be increased in the first week, then increased every few days as necessary up to usual dose, maximum weekly dose increase of 30&#8239;mg; usual dose 60&#8211;120&#8239;mg daily.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Cough in palliative care</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">Initially by mouth using linctus</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>1&#8211;2&#8239;mg every 4&#8211;6&#8239;hours, (by mouth) reduced to 1&#8211;2&#8239;mg twice daily, use twice daily frequency if prolonged use.</p>
                  </li>
                </ul>
              </div>
            </section>
          </section>
          <section class="doseEquivalence">
            <h3>Dose equivalence and conversion</h3>
              <section class="advice DoseEquivalence,IndicationsAndDoseSection">
                <DIV>
                            
                            <p>See <a href="/drug/buprenorphine.html">buprenorphine</a> for dose adjustments in opioid substitution therapy, for patients taking methadone who want to switch to buprenorphine.</p>
                          </DIV>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="unlicensedUse">
          <h2>Unlicensed use</h2>
      
      
          <div class="prescribingInformation">
          <section class="unlicencedUse">
              <section class="advice UnlicencedUse">
                <div>
                              <p>Methadone hydrochloride doses for opioid dependence in the BNF may differ from those in the product literature.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="importantSafetyInformations">
          <h2>Important safety information</h2>
      
      
          <div class="prescribingInformation">
          <section class="importantSafetyInformation">
              <section class="advice ImportantSafetyInformation">
                <div>
                              <p>Methadone oral solution 1&#8239;mg/mL is 2&#189; times the strength of Methadone Linctus (2&#8239;mg/5mL). Many preparations of Methadone oral solution are licensed for opioid drug addiction only but some are also licensed for analgesia in severe pain.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="contraIndications">
          <h2>Contra-indications</h2>
      
            <h3>For all <span>OPIOIDS </span></h3>
            <div id="opioids_contraIndications">
              <p><a href="/drug-class/opioids.html#contraIndications" data-action="load" data-target="#opioids_contraIndications" data-filter="#contraIndications .prescribingInformation">See <span>OPIOIDS </span></a></p>
            </div>
      
          <h3>For <span>METHADONE HYDROCHLORIDE</span></h3>
          <div class="prescribingInformation">
          <section class="generalContraIndications">
              <section class="advice ContraindicationsGroup,GeneralContraindications">
                <p>
                              <span class="contraindication">Phaeochromocytoma</span>
                            </p>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="cautions">
          <h2>Cautions</h2>
      
            <h3>For all <span>OPIOIDS </span></h3>
            <div id="opioids_cautions">
              <p><a href="/drug-class/opioids.html#cautions" data-action="load" data-target="#opioids_cautions" data-filter="#cautions .prescribingInformation">See <span>OPIOIDS </span></a></p>
            </div>
      
          <h3>For <span>METHADONE HYDROCHLORIDE</span></h3>
          <div class="prescribingInformation">
          <section class="generalCautions">
              <section class="advice CautionsGroup,GeneralCautions">
                <p>
                <span class="caution">Family history of sudden death (ECG monitoring recommended)</span>; <span class="caution">history of cardiac conduction abnormalities</span></p>
              </section>
          </section>
          <section class="importantAdvice">
            <h3>Cautions, further information</h3>
              <section class="advice ImportantAdvice">
                <h4>QT-interval prolongation</h4>
                <div>
                              
                              <p>Patients with the following risk factors for QT-interval prolongation should be carefully monitored while taking methadone: heart or liver disease, electrolyte abnormalities, or concomitant treatment with drugs that can prolong QT interval; patients requiring more than 100&#8239;mg daily should also be monitored.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="interactions">
          <h2>Interactions</h2>
      
      
      
          <div class="interactants">
            <h4>Individual interactants:</h4>
            <ul>
              <li><a href="/interaction/methadone.html" class="interactant"><span> Methadone </span></a></li>
            </ul>
          </div>
      
        </section>
      
        <section class="scroll-target" id="sideEffects">
          <h2>Side-effects</h2>
      
            <h3>For all <span>OPIOIDS </span></h3>
            <div id="opioids_sideEffects">
              <p><a href="/drug-class/opioids.html#sideEffects" data-action="load" data-target="#opioids_sideEffects" data-filter="#sideEffects .prescribingInformation">See <span>OPIOIDS </span></a></p>
            </div>
      
          <h3>For <span>METHADONE HYDROCHLORIDE</span></h3>
          <div class="prescribingInformation">
          <section class="generalSideEffects">
            <h3>General side-effects</h3>
            <div class="notKnown">
              <h4>Frequency not known</h4>
                <section class="advice SideEffectsGroup,GeneralSideEffects,SideEffectGroup">
                  <p class="sideEffects">
                  <span class="sideEffect">Asthma exacerbated</span>; <span class="sideEffect">dry eye</span>; <span class="sideEffect">dysuria</span>; <span class="sideEffect">hyperprolactinaemia</span>; <span class="sideEffect">hypothermia</span>; <span class="sideEffect">menstrual cycle irregularities</span>; <span class="sideEffect">mood altered</span>; <span class="sideEffect">nasal dryness</span>; <span class="sideEffect">QT interval prolongation</span>; <span class="sideEffect">vertigo</span></p>
                </section>
            </div>
          </section>
          <section class="specificSideEffects">
            <h3>Specific side-effects</h3>
            <section class="SideEffectsWithRoutes">
              <div class="notKnown">
                <h4>Frequency not known</h4>
                  <section class="advice SideEffectsGroup,SideEffectGroup,SideEffectsWithRoutes">
                    <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use</span></strong></p>
                    <p>
                    <span class="sideEffect">galactorrhoea</span>; <span class="sideEffect">intracranial pressure increased</span></p>
                  </section>
                  <section class="advice SideEffectsGroup,SideEffectGroup,SideEffectsWithRoutes">
                    <p class="specificity"><strong><span class="title">With parenteral use</span></strong></p>
                    <p>
                    <span class="sideEffect">biliary spasm</span>; <span class="sideEffect">muscle rigidity</span>; <span class="sideEffect">oedema</span>; <span class="sideEffect">restlessness</span>; <span class="sideEffect">sexual dysfunction</span>; <span class="sideEffect">sleep disorder</span>; <span class="sideEffect">ureteral spasm</span>; <span class="sideEffect">withdrawal syndrome neonatal</span></p>
                  </section>
              </div>
            </section>
          </section>
          <div class="sideEffectAdvice">
            <h3>Side-effects, further information</h3>
              <section class="advice SideEffectAdvice">
                <div>
                              <p>Methadone is a long-acting opioid therefore effects may be cumulative. </p>
                              <p>Methadone, even in low doses is a special hazard for children; non-dependent adults are also at risk of toxicity; dependent adults are at risk if tolerance is incorrectly assessed during induction.</p>
                            </div>
              </section>
          </div>
          <div class="overdosageInformation">
            <h3>Overdose</h3>
              <section class="advice SideEffectsOverdosageInformation">
                <div>
                              <p>Methadone has a very long duration of action; patients may need to be monitored for long periods following large overdoses.</p>
                            </div>
              </section>
          </div>
          </div>
      
        </section>
      
      
      
        <section class="scroll-target" id="pregnancy">
          <h2>Pregnancy</h2>
      
            <h3>For all <span>OPIOIDS </span></h3>
            <div id="opioids_pregnancy">
              <p><a href="/drug-class/opioids.html#pregnancy" data-action="load" data-target="#opioids_pregnancy" data-filter="#pregnancy .prescribingInformation">See <span>OPIOIDS </span></a></p>
            </div>
      
          <div class="prescribingInformation">
          </div>
      
        </section>
      
        <section class="scroll-target" id="breastfeeding">
          <h2>Breast feeding</h2>
      
      
          <div class="prescribingInformation">
          <section class="generalInformation">
            
              <section class="advice GeneralInformation">
                <div>
                              <p>Withdrawal symptoms in infant; breast-feeding permissible during maintenance but dose should be as low as possible and infant monitored to avoid sedation (high doses of methadone carry an increased risk of sedation and respiratory depression in the neonate).</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="hepaticImpairment">
          <h2>Hepatic impairment</h2>
      
      
          <div class="prescribingInformation">
          <section class="generalInformation">
            
              <section class="advice GeneralInformation">
                <div>
                              <p>Manufacturer advises caution; consider avoiding in severe impairment (risk of increased exposure). </p>
                            </div>
              </section>
          </section>
          <section class="doseAdjustment">
            <h3>Dose adjustments</h3>
              <section class="advice DoseAdjustment">
                <div>
                              <p>Manufacturer advises consider dose reduction.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="renalImpairment">
          <h2>Renal impairment</h2>
      
      
          <div class="prescribingInformation">
          <section class="generalInformation">
              <section class="advice GeneralInformation">
                <div>
                              <p>Avoid use or reduce dose; opioid effects increased and prolonged and increased cerebral sensitivity occurs.</p>
                            </div>
              </section>
          </section>
          
          </div>
      
        </section>
      
      
      
      
        <section class="scroll-target" id="treatmentCessationInformation">
          <h2>Treatment cessation</h2>
      
            <h3>For all <span>OPIOIDS </span></h3>
            <div id="opioids_treatmentCessationInformation">
              <p><a href="/drug-class/opioids.html#treatmentCessationInformation" data-action="load" data-target="#opioids_treatmentCessationInformation" data-filter="#treatmentCessationInformation .prescribingInformation">See <span>OPIOIDS </span></a></p>
            </div>
      
          <h3>For <span>METHADONE HYDROCHLORIDE</span></h3>
          <div class="prescribingInformation">
          <section class="treatmentCessation">
              <section class="advice TreatmentCessation">
                <div>
                              <p>Avoid abrupt withdrawal.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="directionsForAdministration">
          <h2>Directions for administration</h2>
      
      
          <div class="prescribingInformation">
          <section class="directionForAdministration">
              <section class="advice DirectionForAdministration">
                <div>
                              <p>Syrup preserved with hydroxybenzoate (parabens) esters may be incompatible with methadone hydrochloride.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="prescribingAndDispensingInformations">
          <h2>Prescribing and dispensing information</h2>
      
            <h3>For all <span>OPIOIDS </span></h3>
            <div id="opioids_prescribingAndDispensingInformations">
              <p><a href="/drug-class/opioids.html#prescribingAndDispensingInformations" data-action="load" data-target="#opioids_prescribingAndDispensingInformations" data-filter="#prescribingAndDispensingInformations .prescribingInformation">See <span>OPIOIDS </span></a></p>
            </div>
      
          <h3>For <span>METHADONE HYDROCHLORIDE</span></h3>
          <div class="prescribingInformation">
          <section class="prescribingAndDispensingInformation">
              <section class="advice PrescribingAndDispensingInformation">
                <div>
                              <p>Flavours of oral liquid formulations may include tolu.</p>
                            </div>
              </section>
              <section class="advice PrescribingAndDispensingInformation">
                <div>
                              <p>For further information on the use of methadone in palliative care, see<a href="https://www.medicinescomplete.com/#/content/palliative/methadone">www.medicinescomplete.com/#/content/palliative/methadone</a></p>
                            </div>
              </section>
          </section>
          </div>
      
            <h3>For <span>Methadose<sup class="tm">&#174;</sup></span></h3>
            <div id="methadose_prescribingAndDispensingInformations">
              <p><a href="/clinical-medicinal-product-information/methadose.html#prescribingAndDispensingInformations" data-action="load" data-target="#methadose_prescribingAndDispensingInformations" data-filter="#prescribingAndDispensingInformations .prescribingInformation">See <span>Methadose<sup class="tm">&#174;</sup></span></a></p>
            </div>
        </section>
      
      
        <section class="scroll-target" id="patientAndCarerAdvice">
          <h2>Patient and carer advice</h2>
      
            <h3>For all <span>OPIOIDS </span></h3>
            <div id="opioids_patientAndCarerAdvice">
              <p><a href="/drug-class/opioids.html#patientAndCarerAdvice" data-action="load" data-target="#opioids_patientAndCarerAdvice" data-filter="#patientAndCarerAdvice .prescribingInformation">See <span>OPIOIDS </span></a></p>
            </div>
      
          <div class="prescribingInformation">
          </div>
        </section>
      
      
        <section class="scroll-target" id="nationalFunding">
          <h2>National funding/access decisions</h2>
      
      
          <div class="prescribingInformation">
          <section class="niceDecisions">
            <h3>NICE decisions</h3>
            <section class="niceDecision">
              <h5 class="fundingIdentifier"><a href="http://www.nice.org.uk/TA114">NICE TA114</a></h5>
              <section class="advice FundingDecision,NiceDecisions">
                <h4>Methadone and buprenorphine for the management of opioid dependence (January 2007)</h4>
                <div class="niceDecision">
                                <p class="fundingIdentifier">NICE TA114</p>
                                <div>
                                  
                                  <p>Oral methadone and buprenorphine are recommended for maintenance therapy in the management of opioid dependence. Patients should be committed to a supportive care programme including a flexible dosing regimen administered under supervision for at least 3 months, until compliance is assured. Selection of methadone or buprenorphine should be made on a case-by-case basis, but methadone should be prescribed if both drugs are equally suitable.</p>
                                </div>
                                <a href="http://www.nice.org.uk/TA114">www.nice.org.uk/TA114</a>
                              </div>
              </section>
            </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="lessSuitableForPrescribings">
          <h2>Less suitable for prescribing</h2>
      
      
          <div class="prescribingInformation">
          <section class="lessSuitableForPrescribing">
              <section class="advice LessSuitableForPrescribing">
                <div>
                              <p>Methadone linctus is less suitable for prescribing for cough in terminal disease (has a tendency to accumulate).</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
      
        <section class="scroll-target" id="medicinalForms">
          <h2>Medicinal forms</h2>
      
          <section class="licensingVariationStatement">
            <p>There can be variation in the licensing of different medicines containing the same drug.</p>
          </section>
      
            <section class="availableFormsStatement">
              <p>Forms available from special-order manufacturers include: tablet, capsule, oral suspension, oral solution, solution for injection, suppository</p>
            </section>
      
          <section class="medicinalForms">
            <p><a href="../medicinal-forms/methadone-hydrochloride.html"><span>Tablet</span>,  <span>Oral solution</span>,  <span>Solution for injection</span> </a></p>
          </section>
        </section>
      </div>

      
      <div class="back-to-top-container">
        <a class="btn btn-default back-to-top">
        	<span class="hidden-xs">Back to top</span>
        	<span class="icon-chevron-up" style="padding: 0px 4px;"></span>
      	</a>
      </div>    </div>

    <div class="content content-secondary">

        <section class="related-links scroll-target related-treatment-summary" id="related-treatment-summary">
          <h4>Related Treatment Summaries</h4>
          <ul class="">
            <li>
              <a href="../treatment-summary/analgesics.html" class="related-link"><span>Analgesics</span></a>
            </li>
            <li>
              <a href="../treatment-summary/aromatic-inhalations-cough-preparations-and-systemic-nasal-decongestants.html" class="related-link"><span>Aromatic inhalations, cough preparations and systemic nasal decongestants</span></a>
            </li>
            <li>
              <a href="../treatment-summary/substance-dependence.html" class="related-link"><span>Substance dependence</span></a>
            </li>
          </ul>
        </section>

        <section class="classifications scroll-target primary-classifications" id="primary-classifications">
          <div id="primary">
            <p>Other drugs classified as <a href="/drug-classification/primary/methadone-hydrochloride.html" data-target="#primary" data-action="load" class="classification primary-classification">opioids</a></p>
          </div>
        </section>

      

    </div>
  </div>

  
  <div id="global-nav-footer"></div>
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/jquery/jquery-1.10.2.min.js"></script>
  
  
   
  <!-- Bootstrap  -->
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/twitter.bootstrap.min.js"></script>
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/NICE.bootstrap.min.js"></script>
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/nice/NICE.EventTracking.js"></script>
  
  <script src="/scripts/remoteload.js"></script>
  <script src="/scripts/NICE.scrollspy.js"></script>
  <script src="/scripts/NICE.asyoutype.js"></script>
  <script src="/scripts/stickyfill.min.js"></script>
  <script src="/scripts/NICE.bnf.js"></script>
    <script>
  	    (function( $ ) {
  	      $(function() {
  	        var $backToTop = $( '#backToTop' );
  	        var $win = $( window );
  	        var opt = { min: 500, fadeSpeed: 100, scrollSpeed: 300 };
  	  
  	        $( document.body ).on('click', '#backToTop', function( ev ) {
  	          ev.preventDefault();
  	  
  	          $( "html, body" ).animate({ scrollTop: 0 }, opt.scrollSpeed );
  	        });
  	  
  	        $win.on('scroll', function() {
  	          $backToTop[ 'fade' + ( $win.scrollTop() >= opt.min ? 'In' : 'Out' ) ]( opt.fadeSpeed );
  	        });
  	      });
  	    })( jQuery );
  	  </script>
  	  	<script> 
  				var queryMatch = window.location.hash.match("q=([^&]+)");
  				var searchPlaceHolder = "Search BNFâ¦";
  				var global_nav_config = {
  				service: "bnf",
  				header: {
  					skipLinkId: "content-start",
  					cookie: true,
  					auth: {
  						environment: "live" == "live" ? "live" : "beta",
  						provider: "niceAccounts"
  					},
  					search: {
  						url: "/search?q=",
  						query: queryMatch ? decodeURIComponent(queryMatch[1]) : "",
  						autocomplete: "/typeahead?ajax=ajax",
  						placeholder: searchPlaceHolder,
  						onSearching: function(e) {
  								window.location.href = "#Search?q=" + encodeURIComponent(e.query);
  						}
  					},
  					onRendered: "globalNavRendered"
  				}
  	  	};
  	  </script>
  	  
  			<!--[if lt IE 9]>
  					<script src="//cdn.nice.org.uk/global-nav/global-nav.ie8.min.js"></script>
  			<![endif]-->
  			<script src="//cdn.nice.org.uk/global-nav/global-nav.min.js"></script>
  	
  	  
  
  
  
  <!-- Test for touch device -->
  <script type="text/javascript">
    $('body').addClass('ontouchstart' in document.documentElement ? 'touch-screen-device' : 'non-touch-screen-device');
  </script>
  
  <!-- TODO: What is this doing? -->
  <script type="text/javascript">
    $(document).ajaxSend(function (event, jqxhr, settings) { settings.url = settings.url + (~settings.url.indexOf("?") ? "&" : "?")+ "ajax=ajax"; });
  </script></body>
</html>
